Antiemetic control: 5-HT3 antagonists: Review of clinical results, with particular emphasis on ondansetron-Reference-Cited by-同舟云学术

Antiemetic control: 5-HT3 antagonists: Review of clinical results, with particular emphasis on ondansetron

Published:1990-09 Issue:2-3 Volume:17 Page:311-317
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Kidgell A.E.,Butcher M.E.,Brown G.W.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference20 articles.

1. The 5-HT3 antagonist GR38032F is superior to metoclopramide in the prophylaxis of FAC/FEC-induced emesis;Bonneterre,1989

2. A randomised comparative study of the anti-emetic effect and safety of MDL 72222 and ‘Standard anti-emetic therapy’ in patients receiving cisplatin-containing chemotherapy for malignant tumours;Clavel,1989

3. GR38032: a potent and novel inhibitor of cisplatin-induced emesis in the ferret;Costall;British Journal of Pharmacology,1987

4. Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist;Cunningham;Lancet,1987

5. The efficacy of GR38032, an antagonist of 5-hydroxytryptamine-3 (5-HT3) in the prophylaxis of cisplatin (CDDP)-induced nausea and vomiting;Deltann;European Journal of Cancer and Clinical Oncology,1983

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ondansetron: In a class (5HT3) of its own;Seminars in Anesthesia, Perioperative Medicine and Pain;1996-03

2. Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting;Annals of Oncology;1994-11

3. Double-blind comparison of ondansetron, droperidol and saline in the prevention of postoperative nausea and vomiting;British Journal of Anaesthesia;1994-05

4. Psychiatric Complications Associated With Ondansetron;Psychosomatics;1994-03

5. Further Studies of the Antiemetic Activity of Granisetron against Whole Body X-lrradiation or Cisplatin-lnduced Emesis in the Ferret;Pharmacology;1994